1. Near‐infrared fluorescence‐labeled anti‐PD‐L1‐mAb for tumor imaging in human colorectal cancer xenografted mice
- Author
-
Xiaolin Gao, Mingyu Zhang, Rongjun Zhang, Hui-Jie Jiang, Hai-Long Xu, Hao Jiang, Wenbin Pan, and Zhongqi Sun
- Subjects
0301 basic medicine ,programmed death ligand‐1/programmed death ligand‐1 checkpoint ,Immunoconjugates ,medicine.drug_class ,Colorectal cancer ,medicine.medical_treatment ,Mice, Nude ,Spleen ,colorectal cancer ,Monoclonal antibody ,Biochemistry ,B7-H1 Antigen ,Flow cytometry ,03 medical and health sciences ,noninvasive imaging ,0302 clinical medicine ,Western blot ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Molecular Biology ,neoplasms ,Research Articles ,Mice, Inbred BALB C ,medicine.diagnostic_test ,Chemistry ,Optical Imaging ,Antibodies, Monoclonal ,Reproducibility of Results ,Cell Biology ,Immunotherapy ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,Cell culture ,030220 oncology & carcinogenesis ,Cancer research ,Feasibility Studies ,Heterografts ,Female ,immunotherapy ,Colorectal Neoplasms ,Preclinical imaging ,Research Article - Abstract
The expression of programmed death ligand‐1 (PD‐L1) in tumor has been used as a biomarker to predict the anti‐PD‐L1 immunotherapy response. To develop a noninvasive imaging technique to monitor the dynamic changes in PD‐L1 expression in colorectal cancer (CRC), we labeled an anti‐PD‐L1 monoclonal antibody with near‐infrared (NIR) dye and tested the ability of the NIR‐PD‐L1‐mAb probe to monitor the PD‐L1 expression in CRC‐xenografted mice by performing optical imaging. Consistent with the expression levels of PD‐L1 protein in three CRC cell lines in vitro by flow cytometry and Western blot analyses, our in vivo imaging showed the highest fluorescence signal of the xenografted tumors in mice bearing SW620 CRC cells, followed by tumors derived from SW480 and HCT8 cell lines. We detected the highest fluorescent intensity of the tumor at 120 hours after injection of NIR‐PD‐L1‐mAb. The highest fluorescence intensity was seen in the tumor, followed by the spleen and the liver in SW620 xenografted mice. In SW480 and HCT8 xenografted mice, however, the highest fluorescent signals were detected in the spleen, followed by the liver and the tumor. Our findings indicate that SW620 cells express a higher level of PD‐L1, and the NIR‐PD‐L1‐mAb binding to PD‐L1 on the surface of CRC cells was specific. The technique was safe and could provide valuable information on PD‐L1 expression of the tumor for development of a therapeutic strategy of personized targeted immunotherapies as well as treatment response of patients with CRC.
- Published
- 2019